Crohn's Disease - Thorne Research

ReviewCrohn’s Disease94. Braegger CP, Nicholls S, Murch SH, et al.Tumour necrosis factor alpha in stool as amarker of intestinal inflammation. Lancet1992;339:89-91.95. Bamias G, Martin C 3 rd , Marini M, et al.Expression, localization, and functionalactivity of TL1A, a novel Th1-polarizingcytokine in inflammatory bowel disease. JImmunol 2003;171:4868-4874.96. D’Odorico A, Bortolan S, Cardin R, et al.Reduced plasma antioxidant concentrationsand increased oxidative DNA damage ininflammatory bowel disease. Scand JGastroenterol 2001;36:1289-1294.97. Reimund JM, Hirth C, Koehl C, et al. Antioxidantand immune status in active Crohn’sdisease. A possible relationship. Clin Nutr2000;19:43-48.98. Sampietro GM, Cristaldi M, Cervato G, et al.Oxidative stress, vitamin A and vitamin Ebehaviour in patients submitted to conservativesurgery for complicated Crohn’s disease. DigLiver Dis 2002;34:696-701.99. Wendland BE, Aghdassi E, Tam C, et al. Lipidperoxidation and plasma antioxidant micronutrientsin Crohn disease. Am J Clin Nutr2001;74:259-264.100. Levy E, Rizwan Y, Thibault L, et al. Alteredlipid profile, lipoprotein composition, andoxidant and antioxidant status in pediatricCrohn disease. Am J Clin Nutr 2000;71:807-815.101. Kruidenier L, Kuiper I, Lamers CB, VerspagetHW. Intestinal oxidative damage in inflammatorybowel disease: semi-quantification,localization, and association with mucosalantioxidants. J Pathol 2003:201:28-36.102. Irvine EJ, Marshall JK. Increased intestinalpermeability precedes the onset of Crohn’sdisease in a subject with familial risk. Gastroenterology2000;119:1740-1744.103. Secondulfo M, de Magistris L, Fiandra R, etal. Intestinal permeability in Crohn’s diseasepatients and their first degree relatives. DigLiver Dis 2001;33:680-685.104. Breslin NP, Nash C, Hilsden RJ, et al. Intestinalpermeability is increased in a proportion ofspouses of patients with Crohn’s disease. Am JGastroenterol 2001;96:2934-2938.105. Soderholm JD, Olaison G, Lindberg E, et al.Different intestinal permeability patterns inrelatives and spouses of patients with Crohn’sdisease: an inherited defect in mucosaldefence? Gut 1999;44:96-100.106. Zamora SA, Hilsden RJ, Meddings JB, et al.Intestinal permeability before and afteribuprofen in families of children with Crohn’sdisease. Can J Gastroenterol 1999;13:31-36.107. Soderholm JD, Peterson KH, Olaison G, et al.Epithelial permeability to proteins in thenoninflamed ileum of Crohn’s disease?Gastroenterology 1999;117:65-72.108. Poritz LS, Garver KI, Tilberg AF, Koltun WA.Tumor necrosis factor alpha disrupts tightjunction assembly. J Surg Res 2004;116:14-18.109. Ma TY, Iwamoto GK, Hoa NT, et al. TNFalpha-inducedincrease in intestinal epithelialtight junction permeability requires NF-kappaB activation. Am J Physiol Gastrointest LiverPhysiol 2004;286:G367-G376.110. Wild GE, Waschke KA, Bitton A, ThomsonAB. The mechanisms of prednisone inhibitionof inflammation in Crohn’s disease involvechanges in intestinal permeability, mucosalTNF alpha production and nuclear factorkappa B expression. Aliment Pharmacol Ther2003;18:309-317.111. Suenaert P, Bulteel V, Lemmens L, et al. Antitumornecrosis factor treatment restores the gutbarrier in Crohn’s disease. Am J Gastroenterol2002;97:2000-2004.112. Iwata M, Nakano H, Matsuura Y, et al.Intestinal permeability in Crohn’s disease andeffects of elemental dietary therapy. NipponShokakibyo Gakkai Zasshi 2001;98:636-643.[Article in Japanese]113. Wyatt J, Vogelsang H, Hubl W, et al. Intestinalpermeability and the prediction of relapse inCrohn’s disease. Lancet 1993;341:1437-1439.114. Malin M, Isolauri E, Pikkarainen P, et al.Enhanced absorption of macromolecules. Asecondary factor in Crohn’s disease. Dig DisSci 1996;41:1423-1428.115. Arnott ID, Kingstone K, Ghosh S. Abnormalintestinal permeability predicts relapse ininactive Crohn disease. Scand J Gastroenterol2000;35:1163-1169.116. D’Inca R, Di Leo V, Corrao G, et al. Intestinalpermeability test as a predictor of clinicalcourse in Crohn’s disease. Am J Gastroenterol1999;94:2956-2960.117. Jorgensen J, Ranlov PJ, Bjerrum PJ, et al. Is anincreased intestinal permeability a validpredictor of relapse in Crohn disease? Scand JGastroenterol 2001;36:521-527.Alternative Medicine Review ◆ Volume 9, Number 4 ◆ 2004 Page 393Copyright©2004 Thorne Research, Inc. All Rights Reserved. No Reprint Without Written Permission